BNTX logo

BioNTech SE (BNTX) Cash From Operations

Annual CFO:

$224.67M-$5.58B(-96.13%)
December 31, 2024

Summary

  • As of today, BNTX annual cash from operations is $224.67 million, with the most recent change of -$5.58 billion (-96.13%) on December 31, 2024.
  • During the last 3 years, BNTX annual cash from operations has fallen by -$826.94 million (-78.64%).
  • BNTX annual cash from operations is now -98.43% below its all-time high of $14.27 billion, reached on December 31, 2022.

Performance

BNTX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Quarterly CFO:

$132.14M+$953.79M(+116.08%)
June 30, 2025

Summary

  • As of today, BNTX quarterly cash from operations is $132.14 million, with the most recent change of +$953.79 million (+116.08%) on June 30, 2025.
  • Over the past year, BNTX quarterly cash from operations has dropped by -$1.63 billion (-92.49%).
  • BNTX quarterly cash from operations is now -97.27% below its all-time high of $4.84 billion, reached on September 30, 2022.

Performance

BNTX Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFO:

-$1.88B-$1.63B(-647.24%)
June 30, 2025

Summary

  • As of today, BNTX TTM cash from operations is -$1.88 billion, with the most recent change of -$1.63 billion (-647.24%) on June 30, 2025.
  • Over the past year, BNTX TTM cash from operations has dropped by -$5.04 billion (-159.37%).
  • BNTX TTM cash from operations is now -113.27% below its all-time high of $14.16 billion, reached on December 31, 2022.

Performance

BNTX TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BNTX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-96.1%-92.5%-159.4%
3Y3 Years-78.6%-96.8%-118.3%
5Y5 Years+201.1%+888.4%-413.5%

BNTX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-98.4%at low-97.3%+116.1%-113.3%at low
5Y5-Year-98.4%+201.1%-97.3%+116.1%-113.3%at low
All-TimeAll-Time-98.4%+201.1%-97.3%+116.1%-113.3%at low

BNTX Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$132.14M(+116.1%)
-$1.88B(-647.2%)
Mar 2025
-
-$821.66M(-63.9%)
-$251.40M(-211.3%)
Dec 2024
$224.67M(-96.1%)
-$501.21M(+27.1%)
$225.87M(-85.7%)
Sep 2024
-
-$687.85M(-139.1%)
$1.58B(-50.1%)
Jun 2024
-
$1.76B(+610.9%)
$3.16B(-48.6%)
Mar 2024
-
-$344.38M(-140.5%)
$6.15B(+6.6%)
Dec 2023
$5.81B(-59.3%)
$850.76M(-5.3%)
$5.77B(+4.8%)
Sep 2023
-
$898.37M(-81.1%)
$5.51B(-41.7%)
Jun 2023
-
$4.75B(+753.0%)
$9.45B(+6.3%)
Mar 2023
-
-$726.81M(-223.5%)
$8.89B(-37.2%)
Dec 2022
$14.27B(+1256.9%)
$588.71M(-87.8%)
$14.16B(+6.3%)
Sep 2022
-
$4.84B(+15.7%)
$13.32B(+29.6%)
Jun 2022
-
$4.19B(-7.9%)
$10.28B(+72.1%)
Mar 2022
-
$4.54B(+1908.1%)
$5.97B(+467.2%)
DateAnnualQuarterlyTTM
Dec 2021
$1.05B(+6946.4%)
-$251.29M(-114.0%)
$1.05B(-33.5%)
Sep 2021
-
$1.80B(+1590.9%)
$1.58B(+464.5%)
Jun 2021
-
-$120.71M(+67.8%)
-$434.09M(-31.5%)
Mar 2021
-
-$374.96M(-234.8%)
-$330.14M(-2040.0%)
Dec 2020
-$15.36M(+93.1%)
$278.19M(+228.4%)
-$15.43M(+95.8%)
Sep 2020
-
-$216.61M(-1192.5%)
-$365.82M(-80.2%)
Jun 2020
-
-$16.76M(+72.2%)
-$202.96M(+17.8%)
Mar 2020
-
-$60.25M(+16.6%)
-$247.01M(-11.2%)
Dec 2019
-$222.21M(-223.7%)
-$72.21M(-34.4%)
-$222.22M(-48.1%)
Sep 2019
-
-$53.75M(+11.6%)
-$150.01M(-55.8%)
Jun 2019
-
-$60.80M(-71.5%)
-$96.26M(-171.5%)
Mar 2019
-
-$35.46M
-$35.46M
Dec 2018
-$68.64M(-15.8%)
-
-
Dec 2017
-$59.29M
-
-

FAQ

  • What is BioNTech SE annual cash from operations?
  • What is the all-time high annual cash from operations for BioNTech SE?
  • What is BioNTech SE annual cash from operations year-on-year change?
  • What is BioNTech SE quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for BioNTech SE?
  • What is BioNTech SE quarterly cash from operations year-on-year change?
  • What is BioNTech SE TTM cash from operations?
  • What is the all-time high TTM cash from operations for BioNTech SE?
  • What is BioNTech SE TTM cash from operations year-on-year change?

What is BioNTech SE annual cash from operations?

The current annual cash from operations of BNTX is $224.67M

What is the all-time high annual cash from operations for BioNTech SE?

BioNTech SE all-time high annual cash from operations is $14.27B

What is BioNTech SE annual cash from operations year-on-year change?

Over the past year, BNTX annual cash from operations has changed by -$5.58B (-96.13%)

What is BioNTech SE quarterly cash from operations?

The current quarterly cash from operations of BNTX is $132.14M

What is the all-time high quarterly cash from operations for BioNTech SE?

BioNTech SE all-time high quarterly cash from operations is $4.84B

What is BioNTech SE quarterly cash from operations year-on-year change?

Over the past year, BNTX quarterly cash from operations has changed by -$1.63B (-92.49%)

What is BioNTech SE TTM cash from operations?

The current TTM cash from operations of BNTX is -$1.88B

What is the all-time high TTM cash from operations for BioNTech SE?

BioNTech SE all-time high TTM cash from operations is $14.16B

What is BioNTech SE TTM cash from operations year-on-year change?

Over the past year, BNTX TTM cash from operations has changed by -$5.04B (-159.37%)
On this page